PPT1 and lysosomal storage disease: Despite previously reported treatment effects of NALL in other lysosomal storage disorders, such as Niemann–Pick type C (NPC)15,17–23 and GM2 gangliosidosis32–33, NALL failed to produce significant therapeutic benefit in Ppt1−/− mice, regardless of age at treatment initiation.